Robert G. Moussa
CTI - Directors | Robert G. Moussa
Competitive Technologies, Inc.
Robert G. Moussa
Director, Chairman of Compensation Committee, member of Audit Committee and member of Nominating Committee
Robert Moussa currently serves as Chairman and Chief Executive Officer of Dilon Diagnostics, having spent more than 30 years in the healthcare field.
In addition to his role at Dilon, he has held a number of senior positions at both Sherwood Medical Industries and Mallinckrodt Medical.
has extensive experience launching new products in the diagnostic, nuclear medicine and medical device markets.
Before joining Dilon Technologies, Inc., Mr. Moussa served as President and Chief Executive Officer of Robert Moussa & Associates, a consulting firm serving the pharmaceutical, biotechnology and healthcare industries.
Prior to founding this firm, he served in a variety of executive positions with Mallinckrodt, Inc., St. Louis, Missouri, a $2.4 billion healthcare and chemical company.
Mr. Moussa's most recent assignment at Mallinckrodt was President - International, a position he held from 1995 through 1997.
Previously he served as President and Chief Executive Officer - Mallinckrodt Medical, Inc., Mallinckrodt's largest business unit with over $1 billion dollars in revenues (1992-1996).
Before joining Mallinckrodt Medical in 1992, Mr. Moussa served as Mallinckrodt, Inc.'s Group Vice President - International Medical Products, Vice President and General Manager - Medical Products Europe, General Manager of Critical Care, Director of Business Operations and General Sales Manager.
Prior to joining Mallinckrodt, Mr. Moussa held a number of positions during the period 1969 through 1976 with Sherwood Medical, United Kingdom, most recently as Director of Marketing.
Baccalaureate from the Collège du Sacré-Cœur, Beirut, Lebanon, in 1966 and his
Bachelor of Science in Business Administration from Ealing University
, London, England, in 1969.
has also completed executive seminars at the University of California at Berkley, the Aspen Institute, the Wharton Executive School and the Center for Creative Leadership